The effect of Vitamin D on neuropsychiatric conditions;D-vitamins betydning for neuropsykiatriske tilstande

Ugeskrift for Laeger

Volumn 172, Issue 17, 2010, Pages

  Ashkanian, Mahmoud ^a   Tehrani, Elisabeth ^a   Videbech, Poul ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR; VITAMIN D;

ANIMAL; HUMAN; MENTAL DISEASE; METABOLISM; MULTIPLE SCLEROSIS; REVIEW; VITAMIN D DEFICIENCY;

ANIMALS; HUMANS; MENTAL DISORDERS; MULTIPLE SCLEROSIS; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77952311790     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Garcion E, Wion-Barbot N, Montero-Menei CN et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002;13:100-5.
2. Erben RG, Soegiarto DW, Weber K et al. Deletion of deoxyribonucleic acid -binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 2002;16:1524-37.
3. Stumpf WE, Sar M, Clark SA et al. Brain target sites for 1,25-dihydroxyvitamin D3. Science 1982;215:1403-5.
4. Stumpf WE, Clark SA, O'Brien LP et al. 1,25(OH)2 vitamin D3 sites of action in spinal cord and sensory ganglion. Anat Embryol (Berl) 1988;177:307-10.
5. Christakos S, Dhawan P, Peng X et al. New insights into the function and regulation of vitamin D target proteins. J Steroid Biochem Mol Biol 2007;103:405-10.
6. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80:1689S-96S.
7. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116:2062-72.
8. Chaudhuri A. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses 2005;64:608-18.
9. Jørgensen SP, Bartels LE, Agnholt J et al. D-vitamin-insufficiens - en mulig ætiologisk faktor ved autoimmune sygdomme. Ugeskr Læger 2007;169:3655-60.
10. Eyles DW, Smith S, Kinobe R et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005;29:21-30.
11. Darwish H, DeLuca HF. Vitamin D-regulated gene expression. Crit Rev Eukaryot Gene Expr 1993;3:89-116.
12. Musiol IM, Feldman D. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs. Endocrinology 1997;138:12-8.
13. Kalueff AV, Lou YR, Laaksi I et al. Increased anxiety in mice lacking vitamin D -receptor gene. Neuroreport 2004;15:1271-4.
14. Prufer K, Veenstra TD, Jirikowski GF et al. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat 1999;16:135-45.
15. Neveu I, Naveilhan P, Jehan F et al. 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res 1994;24:70-6.
16. Fu GK, Lin D, Zhang MY, Bikle DD et al. Cloning of human 25-hydroxyvitamin -D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997;11:1961-70.
17. Altemus KL, Finger S, Wolf C et al. Behavioral correlates of vitamin D deficiency. Physiol Behav 1987;39:435-40.
18. Armstrong DJ, Meenagh GK, Bickle I et al. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 2007;26:551-4.
19. Eyles D, Brown J, kay-Sim A et al. Vitamin D3 and brain development. -Neuroscience 2003;118:641-53.
20. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999;122:593-624.
21. McGrath J, Saari K, Hakko H et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 2004;67:237-45.
22. Torrey EF, Miller J, Rawlings R et al. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res 1997;28:1-38.
23. Videbech T, Weeke A, Dupont A. Endogenous psychoses and season of birth. Acta Psychiatr Scand 1974;50:202-18.
24. Dalen P. Month of birth and schizophrenia. Acta Psychiatr Scand Suppl 1968;203:55-60.
25. Stumpf WE, O'Brien LP. 1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study. Histochemistry 1987;87:393-406.
26. Lefebvre dC, Montero-Menei CN, Bernard R, Couez D. Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line. J Neurosci Res 2003;71:575-82.
27. McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 2008;22:982-1001.
28. Wilkins CH, Sheline YI, Roe CM et al. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006;14:1032-40.
29. Hoogendijk WJ, Lips P, Dik MG et al. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008;65:508-12.
30. Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects -during winter. Psychopharmacology (Berl) 1998;135:319-23.
31. Jorde R, Sneve M, Figenschau Y et al. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008;264:599-609.
32. Gloth FM, III, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999;3:5-7.
33. Ebers GC, Bulman DE, Sadovnick AD et al. A population-based study of multiple sclerosis in twins. N Engl J Med 1986;315:1638-42.
34. Kurland LT. Epidemiologic characteristics of multiple sclerosis. Am J Med 1952;12:561-71.
35. Hayes CE, Nashold FE, Spach KM et al. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy -le-grand) 2003;49:277-300.
36. Pedersen LB, Nashold FE, Spach KM et al. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res 2007;85:2480-90.
37. Sutherland MK, Somerville MJ, Yoong LK et al. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 1992;13:239-50.
38. Oudshoorn C, Mattace-Raso FU, van d, V et al. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008;25:539-43.
39. Mosekilde L, Nielsen LR, Larsen ER et al. Vitamin-D-mangel. Ugeskr Læger 2005;167:29-33.
40. Videbech P, Tehrani ES. Billeddannende teknikker og et forslag til implementering af et neuropsykiatrisk udredningsprogram for patienter med depression. Ugeskr Læger 2007;169:1431-4.